These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 22658862)

  • 1. Discovery of pyrazole carboxylic acids as potent inhibitors of rat long chain L-2-hydroxy acid oxidase.
    Barawkar DA; Bandyopadhyay A; Deshpande A; Koul S; Kandalkar S; Patil P; Khose G; Vyas S; Mone M; Bhosale S; Singh U; De S; Meru A; Gundu J; Chugh A; Palle VP; Mookhtiar KA; Vacca JP; Chakravarty PK; Nargund RP; Wright SD; Roy S; Graziano MP; Cully D; Cai TQ; Singh SB
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4341-7. PubMed ID: 22658862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent and Selective Inhibitors of Long Chain l-2-Hydroxy Acid Oxidase Reduced Blood Pressure in DOCA Salt-Treated Rats.
    Barawkar DA; Meru A; Bandyopadhyay A; Banerjee A; Deshpande AM; Athare C; Koduru C; Khose G; Gundu J; Mahajan K; Patil P; Kandalkar SR; Niranjan S; Bhosale S; De S; Mukhopadhyay S; Chaudhary S; Koul S; Singh U; Chugh A; Palle VP; Mookhtiar KA; Vacca J; Chakravarty PK; Nargund RP; Wright SD; Roy S; Graziano MP; Singh SB; Cully D; Cai TQ
    ACS Med Chem Lett; 2011 Dec; 2(12):919-23. PubMed ID: 24900281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and structural optimization of pyrazole derivatives as novel inhibitors of Cdc25B.
    Chen HJ; Liu Y; Wang LN; Shen Q; Li J; Nan FJ
    Bioorg Med Chem Lett; 2010 May; 20(9):2876-9. PubMed ID: 20363629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrazole-based cathepsin S inhibitors with improved cellular potency.
    Wei J; Pio BA; Cai H; Meduna SP; Sun S; Gu Y; Jiang W; Thurmond RL; Karlsson L; Edwards JP
    Bioorg Med Chem Lett; 2007 Oct; 17(20):5525-8. PubMed ID: 17822900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biphenyl-4-ylcarbamoyl thiophene carboxylic acids as potent DHODH inhibitors.
    Leban J; Kralik M; Mies J; Baumgartner R; Gassen M; Tasler S
    Bioorg Med Chem Lett; 2006 Jan; 16(2):267-70. PubMed ID: 16246558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of amides derived from 1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT).
    Zheng X; Bair KW; Bauer P; Baumeister T; Bowman KK; Buckmelter AJ; Caligiuri M; Clodfelter KH; Feng Y; Han B; Ho YC; Kley N; Li H; Liang X; Liederer BM; Lin J; Ly J; O'Brien T; Oeh J; Oh A; Reynolds DJ; Sampath D; Sharma G; Skelton N; Smith CC; Tremayne J; Wang L; Wang W; Wang Z; Wu H; Wu J; Xiao Y; Yang G; Yuen PW; Zak M; Dragovich PS
    Bioorg Med Chem Lett; 2013 Oct; 23(20):5488-97. PubMed ID: 24021463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thieno[3,2-c]pyrazoles: a novel class of Aurora inhibitors with favorable antitumor activity.
    Bindi S; Fancelli D; Alli C; Berta D; Bertrand JA; Cameron AD; Cappella P; Carpinelli P; Cervi G; Croci V; D'Anello M; Forte B; Giorgini ML; Marsiglio A; Moll J; Pesenti E; Pittalà V; Pulici M; Riccardi-Sirtori F; Roletto F; Soncini C; Storici P; Varasi M; Volpi D; Zugnoni P; Vianello P
    Bioorg Med Chem; 2010 Oct; 18(19):7113-20. PubMed ID: 20817473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High resolution crystal structure of rat long chain hydroxy acid oxidase in complex with the inhibitor 4-carboxy-5-[(4-chlorophenyl)sulfanyl]-1, 2, 3-thiadiazole. Implications for inhibitor specificity and drug design.
    Chen ZW; Vignaud C; Jaafar A; Lévy B; Guéritte F; Guénard D; Lederer F; Mathews FS
    Biochimie; 2012 May; 94(5):1172-9. PubMed ID: 22342614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and optimization of pyrazoline compounds as B-Raf inhibitors.
    Duffey MO; Adams R; Blackburn C; Chau RW; Chen S; Galvin KM; Garcia K; Gould AE; Greenspan PD; Harrison S; Huang SC; Kim MS; Kulkarni B; Langston S; Liu JX; Ma LT; Menon S; Nagayoshi M; Rowland RS; Vos TJ; Xu T; Yang JJ; Yu S; Zhang Q
    Bioorg Med Chem Lett; 2010 Aug; 20(16):4800-4. PubMed ID: 20634068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of novel quinoline carboxylic acid series as DGAT1 inhibitors.
    Zhou G; Ting PC; Wishart G; Zorn N; Aslanian RG; Lin M; Smith M; Walker SS; Cook J; Van Heek M; Lachowicz J
    Bioorg Med Chem Lett; 2014 Apr; 24(7):1790-4. PubMed ID: 24618302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The discovery of novel benzofuran-2-carboxylic acids as potent Pim-1 inhibitors.
    Xiang Y; Hirth B; Asmussen G; Biemann HP; Bishop KA; Good A; Fitzgerald M; Gladysheva T; Jain A; Jancsics K; Liu J; Metz M; Papoulis A; Skerlj R; Stepp JD; Wei RR
    Bioorg Med Chem Lett; 2011 May; 21(10):3050-6. PubMed ID: 21507633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III).
    Carrión MD; López Cara LC; Camacho ME; Tapias V; Escames G; Acuña-Castroviejo D; Espinosa A; Gallo MA; Entrena A
    Eur J Med Chem; 2008 Nov; 43(11):2579-91. PubMed ID: 18325637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of some 5-phenylisoxazole-3-carboxylic acid derivatives as potent xanthine oxidase inhibitors.
    Wang S; Yan J; Wang J; Chen J; Zhang T; Zhao Y; Xue M
    Eur J Med Chem; 2010 Jun; 45(6):2663-70. PubMed ID: 20189693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and bioevaluation of 1-phenyl-pyrazole-4-carboxylic acid derivatives as potent xanthine oxidoreductase inhibitors.
    Li J; Wu F; Liu X; Zou Y; Chen H; Li Z; Zhang L
    Eur J Med Chem; 2017 Nov; 140():20-30. PubMed ID: 28918097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-oxime pyrazole based inhibitors of B-Raf kinase.
    Newhouse BJ; Hansen JD; Grina J; Welch M; Topalov G; Littman N; Callejo M; Martinson M; Galbraith S; Laird ER; Brandhuber BJ; Vigers G; Morales T; Woessner R; Randolph N; Lyssikatos J; Olivero A
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3488-92. PubMed ID: 21536432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery of fused pyrrole carboxylic acids as novel, potent D-amino acid oxidase (DAO) inhibitors.
    Sparey T; Abeywickrema P; Almond S; Brandon N; Byrne N; Campbell A; Hutson PH; Jacobson M; Jones B; Munshi S; Pascarella D; Pike A; Prasad GS; Sachs N; Sakatis M; Sardana V; Venkatraman S; Young MB
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3386-91. PubMed ID: 18455394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist.
    Brotherton-Pleiss CE; Dillon MP; Ford AP; Gever JR; Carter DS; Gleason SK; Lin CJ; Moore AG; Thompson AW; Villa M; Zhai Y
    Bioorg Med Chem Lett; 2010 Feb; 20(3):1031-6. PubMed ID: 20045645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rational approach for the design and synthesis of 1-acetyl-3,5-diaryl-4,5-dihydro(1H)pyrazoles as a new class of potential non-purine xanthine oxidase inhibitors.
    Nepali K; Singh G; Turan A; Agarwal A; Sapra S; Kumar R; Banerjee UC; Verma PK; Satti NK; Gupta MK; Suri OP; Dhar KL
    Bioorg Med Chem; 2011 Mar; 19(6):1950-8. PubMed ID: 21353569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and structure-activity relationships of pyrazole derivatives as potential FabH inhibitors.
    Lv PC; Sun J; Luo Y; Yang Y; Zhu HL
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4657-60. PubMed ID: 20594840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of 1-(2,4-dichlorophenyl)-4-ethyl-5-(5-(2-(4-(trifluoromethyl)phenyl)ethynyl)thiophen-2-yl)-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide as a potential peripheral cannabinoid-1 receptor inverse agonist.
    Hung MS; Chang CP; Li TC; Yeh TK; Song JS; Lin Y; Wu CH; Kuo PC; Amancha PK; Wong YC; Hsiao WC; Chao YS; Shia KS
    ChemMedChem; 2010 Sep; 5(9):1439-43. PubMed ID: 20652930
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.